JUN 24, 2019 9:55 PM PDT

Preventing inflammation to manage cancer

New research led by Dipak Panigrahy, MD, and Allison Gartung, PhD, of the Cancer Center at Beth Israel Deaconess Medical Center (BIDMC) suggests that traditional cancer treatments may be doing more harm than good – particularly when it comes to inflammation and new tumor growth. The study was published online in The Journal of Clinical Investigation.

"Cancer therapy is a double-edged sword, as dying cancer cells can trigger inflammation and promote the growth of microscopic cancerous cells," said Panigrahy. "Surgery, chemotherapy and radiation can all induce the body's inflammatory/immunosuppressive injury response. Even anesthetics can impair the resolution of inflammation."

The idea is that physiologic stress, which could come in any of the forms that Panigrahy mentions above, can trigger microscopic cancers to grow into new tumors. In order to prevent that, Panigrahy and colleagues thought to try blocking of the inflammatory cascade and/or accelerating the resolution of inflammation.

One method through which they tried this process was via administering a nonsteroidal anti-inflammatory drug called ketorolac before surgery; they also tired administering preoperative resolvins -- naturally occurring anti-inflammatory factors that are made by the human body. Both of these processes eliminated the spread of cancer cells in several tumor-resection models, meaning that they have potential for improving anti-inflammatory cancer treatments in the future.

Managing inflammation could help patients with cancer. Photo: Pixabay

While the researchers conducted their study on animal models, not humans, co-author Vikas P. Sukhatme, MD, ScD, and Dean of Emory University School of Medicine, says "Collectively, our findings suggest a potential paradigm shift in our approach to resectable cancers. Clinical trials are now urgently needed to validate these animal studies."

Sources: Science Daily, The Journal of Clinical Investigation

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
APR 14, 2021
Clinical & Molecular DX
AI-Powered Imaging System Can Tell If a Patient Is Cancer-Free
APR 14, 2021
AI-Powered Imaging System Can Tell If a Patient Is Cancer-Free
A patient undergoes chemotherapy and radiation for rectal cancer. How do doctors know whether all the malignant tissue h ...
APR 16, 2021
Cancer
Ion pump delivers chemotherapy directly to brain tumors
APR 16, 2021
Ion pump delivers chemotherapy directly to brain tumors
New research published in Advanced Materials Technologies highlights a development in fighting glioblastoma. The study f ...
APR 04, 2021
Drug Discovery & Development
Ion-Pump for Chemotherapy
APR 04, 2021
Ion-Pump for Chemotherapy
Patients of malignant brain tumors experience recurrences even after subsequent treatments. To address this issue, scien ...
APR 25, 2021
Genetics & Genomics
How Did the Chernobyl Disaster Affect Human Health?
APR 25, 2021
How Did the Chernobyl Disaster Affect Human Health?
It's been about 35 years since the disaster at the Chernobyl nuclear power plant. Now researchers have investigated whet ...
MAY 06, 2021
Cancer
What accounts for the disparities in mortality rates from kidney cancer?
MAY 06, 2021
What accounts for the disparities in mortality rates from kidney cancer?
New research published in the journal Cancers attempts to address gaps in data regarding mortality risk from advanced-st ...
MAY 16, 2021
Cancer
Can you guess which drug is both antiviral and immunotherapeutic?
MAY 16, 2021
Can you guess which drug is both antiviral and immunotherapeutic?
Hepatitis B virus (HBV) is the most common cause of liver cancer in the world, resulting in approximately 880,000 deaths ...
Loading Comments...